Elevidys Kit Patient Weight 26.5 - 27.4 KG

RxCUI: 2641722
RxNorm name: Elevidys Kit Patient Weight 26.5 - 27.4 KG
Display name: Elevidys Kit Patient Weight 26.5 - 27.4 KG
Full name: Elevidys Kit Patient Weight 26.5 - 27.4 KG
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:53

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125781	ELEVIDYS	delandistrogene moxeparvovec-rokl	351(a)	Rx	2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ELEVIDYS	DELANDISTROGENE MOXEPARVOVEC-ROKL	Sarepta Therapeutics, Inc.	3525abcd-fbd2-46c5-9706-cffdf2e8a361	2026-08-12	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2641722

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
3525abcd-fbd2-46c5-9706-cffdf2e8a361	{27 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit 26.5 - 27.4 KG] [BPCK] · ELEVIDYS Kit Patient Weight 26.5 - 27.4 KG [PSN] · Elevidys Kit Patient Weight 26.5 - 27.4 KG [SY]	3	11	These highlights do not include all the information needed to use ELEVIDYS ® safely and effectively. See full prescribing information for ELEVIDYS. ELEVIDYS (delandistrogene moxeparvovec-rokl) suspension, for intravenous infusion Initial U.S. Approval: 2023	20251121